Skip to main content

Table 1 Baseline characteristics of the patients with thyroid cancer and the control group

From: Low BMI and low TSH value as risk factors related to lower bone mineral density in postmenospausal women under levothyroxine therapy for differentiated thyroid carcinoma

Variable

Patients

Control group

P value

Age (years-old)

58.43 ± 8.37

58.43 ± 8.40

0.968

Age at menopause (years-old)

47.19 ± 5.12

46.51 ± 5.33

0.235

Post-menopause time (years)

11.24 ± 9.54

11.93 ± 8.92

0.407

Caucasian (%)

92.6

91.74

0.801

Post-menopausal hormonal therapy (%)

19.2

27.5

0.150

BMI (kg/m2)

27.90 ± 4.51

28.33 ± 4.77

0.667

TSH (μIU/ml)

0.21 ± 0.28

2.27 ± 1.02

<0.001